FA tells me they haven't sold much due to the age demographic limitation of wheezo even in a small market like Australia (given pharmacies will be the same worldwide) so this quarterly revenue will be well below what the market is expecting especially given the $6-8M revenue guideline RSH has stated to the market and normally when a company miss their own guideline by a lot the pps will get smashed more by the market so they only have 1 month to turn this around with more sale or news.....
chart, page-1149
Add RSH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.4¢ |
Change
0.004(13.3%) |
Mkt cap ! $36.03M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.4¢ | 3.0¢ | $36.75K | 1.184M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 224180 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 79999 | 1 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
3.4¢ |
Change
0.004 ( 13.3 %) |
||||
| Open | High | Low | Volume | ||
| 3.2¢ | 3.4¢ | 3.2¢ | 71127 | ||
| Last updated 14.52pm 03/05/2024 ? | |||||
| RSH (ASX) Chart |